Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
PhD Studentship: LLM-Based Agentic AI: Foundations, Systems & Applications – PhD (University Funded)
reply. LLM-based agents is becoming a key part of our everyday life and work, handling multi-step actions in a variety of application domains. However, an important open challenge is making these agents
-
of reinforcement learning or agent-based systems. LanguagesENGLISHLevelExcellent Research FieldComputer science » Computer systemsYears of Research Experience1 - 4 Additional Information Benefits • Full funding
-
test novel psychotropic and neurological agents. The course will offer you insights into a range of fields including molecular biology, brain imaging, behavioural research and epidemiology. It is
-
fungal infections. Emerging research is exploring radiometals conjugated with targeting molecules for in vivo imaging of infections via PET or SPECT. These agents can also be linked to therapeutics
-
fungal infections. Emerging research is exploring radiometals conjugated with targeting molecules for in vivo imaging of infections via PET or SPECT. These agents can also be linked to therapeutics
-
networks continuously generate sensitive data. You will investigate adaptive learning frameworks – such as multi-agent or multi-task approaches – that ensure robustness, explainability, and trust across
-
in the Cloud–Edge Continuum Non-Invasive and Semantic-based IoT stream processing framework with Agentic AI for Next-Generation Trustworthy Wearable and Ambient Systems Trust and Generative AI in Agile
-
PhD Studentship: The Role of O-glycosylation of the Stalk Region of the Immunoglobulin Receptor GPVI
based in group of Dr Alexandre Slater and Prof Steve Watson within the Birmingham Platelet group at the University of Birmingham, Department of Cardiovascular Sciences. Dr Slater’s interests have focussed
-
themselves. Students are expected to spend at least 36 hours a week on their research project, and to attend the University in person for most of their time. Normally, they will be based at the Merchiston
-
neuroprotective effects. Camptothecin – A clinically relevant anticancer agent targeting Topoisomerase I. In collaboration with Prozomix Ltd. (an industrial leader in enzyme development), this project will